Weed (BUDZ) Shares Outstanding (Diluted Average) (2010 - 2026)

Weed (BUDZ) recorded quarterly Shares Outstanding (Diluted Average) of $147.5 million in Q1 2026, up 8.53% quarter-over-quarter from $135.9 million in Q4 2025, and up 11.39% on a YoY basis from $132.4 million in Q1 2025.

Weed (BUDZ) Shares Outstanding (Diluted Average) (2010 - 2026) Analysis & Trends

Weed's Shares Outstanding (Diluted Average) history runs 7 years deep, the most recent figure standing at $147.5 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) rose 11.39% year-over-year to $147.5 million; the TTM figure through Mar 2026 stood at $147.5 million (up 11.39% YoY), while the FY2025 annual figure was $135.9 million, up 9.5% from the prior year.
  • Shares Outstanding (Diluted Average) was $147.5 million for Q1 2026 at Weed, up from $135.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $147.5 million in Q1 2026 to a low of $123.7 million in Q4 2023.
  • Historically, Shares Outstanding (Diluted Average) has averaged $130.9 million across 4 years, with a median of $129.1 million in 2024.
  • The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) increased 0.34% in 2024, then climbed 11.39% in 2026.
  • A 4-year view of Shares Outstanding (Diluted Average) shows it stood at $123.7 million in 2023, then advanced by 0.34% to $124.1 million in 2024, then climbed by 9.5% to $135.9 million in 2025, then gained by 8.53% to $147.5 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $147.5 million (Q1 2026), $135.9 million (Q4 2025), and $134.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.18 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 228.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Weed - - - 147.51 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 147.51 Mn
Dec 31, 2025 135.92 Mn
Sep 30, 2025 134.78 Mn
Jun 30, 2025 135.93 Mn
Mar 31, 2025 132.43 Mn
Dec 31, 2024 124.13 Mn
Sep 30, 2024 125.68 Mn
Jun 30, 2024 125.18 Mn
Mar 31, 2024 123.81 Mn
Dec 31, 2023 123.71 Mn
Mar 31, 2012 13.74 Mn
Dec 31, 2011 12.13 Mn
Sep 30, 2011 11.77 Mn
Jun 30, 2011 11.74 Mn
Mar 31, 2011 11.67 Mn
Dec 31, 2010 11.26 Mn
Sep 30, 2010 11.34 Mn
Jun 30, 2010 11.07 Mn